Gv 2021 Gp, L.L.C. bought $5.0M of Prime Medicine (PRME)

Executed Aug 1 2025, disclosed Aug 5 2025, 4 days later.

Value, as filed

$5.0M

1,500,000 sh × $3.30

Executed

Aug 1 2025

the trade date, as filed

Disclosed

Aug 5 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-25.1%

-7.7% from execution

Over the 21 trading sessions from the disclosed entry session (Aug 5 2025), the stock returned -25.1% (delay-adjusted); from the execution session (Aug 1 2025), -7.7%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

GC Gv 2021 Gp, L.L.C. 10% owner profile →

Gv 2021 Gp, L.L.C. (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in PRME. Across 1 priced purchase filing, the average 21-session return was -7.7% from execution and -25.1% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of PRME (1,500,000 sh × $3.30, as filed), executed Aug 1 2025.

The name

PRME PRME PRME · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→